STTK
Shattuck Labs, Inc.
Key Financials
Operating Income
$-51508000
↑ 36.1%
Revenue
$1.0M
↓ 82.5%
Net Income
$-48809000
↑ 35.3%
Total Assets
$91.0M
↓ 0.0%
Total Liabilities
$8.6M
↓ 24.4%
EPS (Diluted)
$-0.70
↑ 53.0%
Shareholders' Equity
$82.4M
↑ 3.5%
Cash & Equivalents
$54.2M
↓ 5.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| ARS | 4/8/2026 | View on SEC |
| DEFA14A | 4/8/2026 | View on SEC |
| DEF 14A | 4/8/2026 | View on SEC |
| 10-K | 3/5/2026 | View on SEC |
| 8-K | 3/5/2026 | View on SEC |
| SCHEDULE 13G | 2/6/2026 | View on SEC |
| 8-K | 2/5/2026 | View on SEC |
| 4 | 1/27/2026 | View on SEC |
| 4 | 1/27/2026 | View on SEC |
| 4 | 1/27/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | STTK |
| Company Name | Shattuck Labs, Inc. |
| CIK | 1680367 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 512-900-4690 |